The AI platform accelerating clinical trials
Biorce is a Barcelona-based AI clinical trials platform company. Its flagship product, Aika, is an AI-native platform that unifies protocol design, feasibility analysis, and regulatory planning for clinical trials. Built on data from approximately one million real clinical trials, Aika provides explainable AI to help pharmaceutical sponsors and CROs accelerate trial setup, reduce protocol amendments, and cut trial costs by over 50%. Founded in 2024 by Pedro Coelho, Clara Bernardes, José Faria, and Diogo Pisoeiro, Biorce raised $52M in a Series A led by DST Global.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMar 2025
Create a free account to see which investors have funded this company.
Create Free Account
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Anduril Industries is a defense technology company with a mission to transform US and allied mili...
